Singapore-headquartered Klinify has secured an undisclosed investment from healthcare services provider Zuellig Pharma.
As per a report published on e27, the startup will utilize the funding to focus on regional expansion and fuel product development. It will leverage Zuellig’s network to establish its presence in other Asian countries. It has already stepped into Malaysia and is adopted by group practices with 22 clinics in the nation.
Klinify Founder and CEO Krishanthan Surendran, reiterated the plans post funding, saying, this partnership will enable them an access to newer markets and wider userbase. They will be expanding to other nation where Zuellig Pharma has a presence, including Brunei Darussalam, the Philippines, Vietnam, Cambodia, South Korea, Hong Kong, Myanmar, Thailand, Indonesia, Macau, and Taiwan.
Prior to this, Klinify had raised $600K from Jungle Ventures in February 2014. Its application makes managing patient records much easier. There are many platforms out there that make this possible, however, it differs from them simply by reducing that “one” extra step, which includes, clinics or doctors to type that information in order to maintain a record.
Doctors can use its tablet application to simply write away their prescriptions just the way they would do with papers, but digitally. They can simply write away and even refer to the previous subscriptions. Also, users view these patient records in the cloud anytime. You can flip through various digital prescriptions or notes stored in a patient’s folder. Also, the doctors can bookmark certain important files for easy accessibility.
It is now seeking to develop its platform into a “one-stop shop” for doctors. Maarten Kelder, Zuellig Pharma Head of Strategy & Solutions, said,
We will do this by making existing Zuellig Pharma services such as product ordering and inventory management available through the application. This will make it easy for doctors to automate these processes, reducing the complexity of clinic management.